BBIOBridgeBio Pharma, Inc.

$14B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$184M

Net Income

-$131M

EPS (Diluted)

$-1.42

Cash Flow

Operating Cash Flow

-$137M

Free Cash Flow

-$155M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$465M

Total Liabilities

$566M

Stockholders' Equity

-$164M

Cash & Equivalents

$436M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$260,000	+100.0%
Operating Income	-$184M	-$44M	-318.8%
Net Income	-$131M	-$31M	-327.8%

BBIO FY 2018 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena